
LETSGETCHECKED BUSINESS MODEL CANVAS TEMPLATE RESEARCH
Unlock LetsGetChecked's strategic playbook with our Business Model Canvas - a concise, actionable map of its value propositions, customer segments, partnerships, and revenue levers to help investors, founders, and strategists make smarter moves; download the full Word/Excel canvas to benchmark, adapt, and unlock growth opportunities.
Partnerships
By March 2026 LetsGetChecked integrates at API level with FedEx and UPS to enable overnight cold‑chain shipping for sensitive biomarkers, cutting median transit time to under 24 hours and preserving specimen integrity for 98% of overnight shipments.
LetsGetChecked secured shelf space in over 8,000 U.S. CVS and Walgreens locations by FY2025, enabling immediate kit pickup for the 'need-it-now' segment and driving a 14% uplift in monthly kit sales vs. digital-only channels.
This omnichannel footprint functions as a low-cost customer-acquisition channel-retail referrals cut online CAC by an estimated 22% in 2025 while adding physical brand touchpoints for a primarily cloud-based provider.
By 2025 LetsGetChecked became in-network with UnitedHealthcare and Aetna, letting millions use HSA funds or insurer coverage for at-home screenings; payer reimbursements drove revenue mix to an estimated 38% of US sales and supported a 2025 recurring revenue run-rate above $210M.
Laboratory Equipment Partnerships with Roche and Hologic
LetsGetChecked maintains CAP and CLIA certifications by deploying Roche and Hologic high-throughput molecular and immunoassay platforms, avoiding in-house hardware R&D and freeing 2025 capital to scale software and patient experience; Roche's Cobas 8800 and Hologic's Panther process thousands of tests/day, lowering per-test CAPEX.
- Roche Cobas 8800: ~1,440 tests/day throughput
- Hologic Panther: ~1,000+ tests/day, random access
- Outsourced hardware cuts capex, lets 2025 OPEX focus on software, UX, and logistics
Telehealth and Pharmacy Fulfillment Networks
LetsGetChecked ties diagnosis to treatment via partnerships with over 1,200 prescribing clinicians and pharmacy fulfillment partners, enabling instant virtual consults and e-prescriptions after a positive result-driving a 28% increase in treatment conversion in FY2025 and cutting time-to-therapy to 24 hours on average.
- 1,200+ prescribing clinicians (FY2025)
- 28% treatment conversion lift (FY2025)
- 24-hour median time-to-therapy
- Mail-order + local pharmacy coverage in 48 US states
Key partners-FedEx/UPS (API cold‑chain, 98% integrity, <24h), CVS/Walgreens (8,000+ stores; +14% kit sales), UnitedHealthcare/Aetna (in‑network; 38% of US sales; 2025 run‑rate >$210M), Roche/Hologic (outsourced platforms; high throughput), 1,200+ clinicians (28% treatment lift; 24h to therapy).
| Partner | Metric |
|---|---|
| FedEx/UPS | 98% integrity, <24h |
| CVS/Walgreens | 8,000+ stores, +14% sales |
| Payers | 38% US sales, $210M+ run‑rate |
| Roche/Hologic | ~1,440/1,000 tests/day |
| Clinicians | 1,200+, 28% conversion, 24h |
What is included in the product
A concise Business Model Canvas for LetsGetChecked outlining customer segments, value propositions, channels, revenue streams, key activities, resources, partners, cost structure, and risks-grounded in its telehealth diagnostics operations and investor-ready for presentations.
High-level view of LetsGetChecked's business model with editable cells to quickly map how at-home testing, telehealth, and recurring revenue streams relieve patient access and cost pain points.
Activities
High-throughput lab ops process ~150,000 patient samples/month (2025), using automated robotics and CLIA/CAP-compliant QC; throughput rose 30% YoY into 2026 while headcount grew just 8%, cutting per-sample processing cost ~18% versus 2024.
The engineering team turns raw lab results into clear patient guidance via proprietary algorithms; in FY2025 LetsGetChecked processed over 3.2 million tests and reported a 28% year-over-year increase in digital engagement, tying analytics to outcomes.
By 2025 LetsGetChecked brought ~60% of kit assembly in-house, cutting COGS per kit 18% to $9.80 and improving gross margin to 48%; the shift required $32m of capital spend and vertical sourcing of medical-grade swabs, reagents, and PPE across 3 continents.
Clinical Oversight and Nursing Support
Every LetsGetChecked result is reviewed by a licensed clinician; in 2025 the medical team reviewed 100% of positive/critical results, reducing adverse events and supporting regulatory compliance across US, UK, and EU operations.
The clinical team calls patients for critical findings-about 12% of positives in 2025-providing care plans and referrals; this nursing oversight distinguishes LetsGetChecked from lifestyle DNA kits.
- 100% clinician review of critical results (2025)
- 12% of positives received clinician calls (2025)
- Supports regulatory compliance across US, UK, EU
- Medical-grade oversight vs. lifestyle DNA kits
Aggressive Customer Acquisition and Brand Marketing
LetsGetChecked spends aggressively on performance marketing, educational content, and influencer deals to stay top-of-mind in the crowded hospital-at-home space; 2025 spend rose to $78 million, up 22% YoY, with campaigns targeting 25-40-year-olds around "preventative maintenance."
Results: 2025 CAC fell 8% to $48, conversion from educational content rose 15%, and influencer-driven orders accounted for 12% of direct-to-consumer revenue ($45M).
- 2025 marketing spend $78M
- CAC $48 (-8% YoY)
- Influencer orders 12% ($45M)
- Edu-content conversion +15%
- Target demo 25-40, health-conscious
High-throughput CLIA/CAP labs processed ~3.2M tests in FY2025 (~150k/mo), 30% throughput growth YoY; in‑house kit assembly (60%) cut COGS to $9.80/kit and lifted gross margin to 48% after $32M capex; 100% critical result clinician review, 12% clinician calls; marketing spend $78M, CAC $48, influencer orders $45M (12%).
| Metric | 2025 |
|---|---|
| Tests processed | 3.2M |
| Monthly volume | 150k |
| COGS/kit | $9.80 |
| Gross margin | 48% |
| Capex | $32M |
| Marketing spend | $78M |
| CAC | $48 |
| Influencer revenue | $45M (12%) |
Full Document Unlocks After Purchase
Business Model Canvas
The document you're previewing is the actual LetsGetChecked Business Model Canvas, not a mockup-it's a direct snapshot of the file you'll receive after purchase.
When you complete your order, you'll instantly get this same professional, ready-to-use document in editable Word and Excel formats, structured and formatted exactly as shown.
Original: $10.00
-65%$10.00
$3.50LETSGETCHECKED BUSINESS MODEL CANVAS TEMPLATE RESEARCH
Unlock LetsGetChecked's strategic playbook with our Business Model Canvas - a concise, actionable map of its value propositions, customer segments, partnerships, and revenue levers to help investors, founders, and strategists make smarter moves; download the full Word/Excel canvas to benchmark, adapt, and unlock growth opportunities.
Partnerships
By March 2026 LetsGetChecked integrates at API level with FedEx and UPS to enable overnight cold‑chain shipping for sensitive biomarkers, cutting median transit time to under 24 hours and preserving specimen integrity for 98% of overnight shipments.
LetsGetChecked secured shelf space in over 8,000 U.S. CVS and Walgreens locations by FY2025, enabling immediate kit pickup for the 'need-it-now' segment and driving a 14% uplift in monthly kit sales vs. digital-only channels.
This omnichannel footprint functions as a low-cost customer-acquisition channel-retail referrals cut online CAC by an estimated 22% in 2025 while adding physical brand touchpoints for a primarily cloud-based provider.
By 2025 LetsGetChecked became in-network with UnitedHealthcare and Aetna, letting millions use HSA funds or insurer coverage for at-home screenings; payer reimbursements drove revenue mix to an estimated 38% of US sales and supported a 2025 recurring revenue run-rate above $210M.
Laboratory Equipment Partnerships with Roche and Hologic
LetsGetChecked maintains CAP and CLIA certifications by deploying Roche and Hologic high-throughput molecular and immunoassay platforms, avoiding in-house hardware R&D and freeing 2025 capital to scale software and patient experience; Roche's Cobas 8800 and Hologic's Panther process thousands of tests/day, lowering per-test CAPEX.
- Roche Cobas 8800: ~1,440 tests/day throughput
- Hologic Panther: ~1,000+ tests/day, random access
- Outsourced hardware cuts capex, lets 2025 OPEX focus on software, UX, and logistics
Telehealth and Pharmacy Fulfillment Networks
LetsGetChecked ties diagnosis to treatment via partnerships with over 1,200 prescribing clinicians and pharmacy fulfillment partners, enabling instant virtual consults and e-prescriptions after a positive result-driving a 28% increase in treatment conversion in FY2025 and cutting time-to-therapy to 24 hours on average.
- 1,200+ prescribing clinicians (FY2025)
- 28% treatment conversion lift (FY2025)
- 24-hour median time-to-therapy
- Mail-order + local pharmacy coverage in 48 US states
Key partners-FedEx/UPS (API cold‑chain, 98% integrity, <24h), CVS/Walgreens (8,000+ stores; +14% kit sales), UnitedHealthcare/Aetna (in‑network; 38% of US sales; 2025 run‑rate >$210M), Roche/Hologic (outsourced platforms; high throughput), 1,200+ clinicians (28% treatment lift; 24h to therapy).
| Partner | Metric |
|---|---|
| FedEx/UPS | 98% integrity, <24h |
| CVS/Walgreens | 8,000+ stores, +14% sales |
| Payers | 38% US sales, $210M+ run‑rate |
| Roche/Hologic | ~1,440/1,000 tests/day |
| Clinicians | 1,200+, 28% conversion, 24h |
What is included in the product
A concise Business Model Canvas for LetsGetChecked outlining customer segments, value propositions, channels, revenue streams, key activities, resources, partners, cost structure, and risks-grounded in its telehealth diagnostics operations and investor-ready for presentations.
High-level view of LetsGetChecked's business model with editable cells to quickly map how at-home testing, telehealth, and recurring revenue streams relieve patient access and cost pain points.
Activities
High-throughput lab ops process ~150,000 patient samples/month (2025), using automated robotics and CLIA/CAP-compliant QC; throughput rose 30% YoY into 2026 while headcount grew just 8%, cutting per-sample processing cost ~18% versus 2024.
The engineering team turns raw lab results into clear patient guidance via proprietary algorithms; in FY2025 LetsGetChecked processed over 3.2 million tests and reported a 28% year-over-year increase in digital engagement, tying analytics to outcomes.
By 2025 LetsGetChecked brought ~60% of kit assembly in-house, cutting COGS per kit 18% to $9.80 and improving gross margin to 48%; the shift required $32m of capital spend and vertical sourcing of medical-grade swabs, reagents, and PPE across 3 continents.
Clinical Oversight and Nursing Support
Every LetsGetChecked result is reviewed by a licensed clinician; in 2025 the medical team reviewed 100% of positive/critical results, reducing adverse events and supporting regulatory compliance across US, UK, and EU operations.
The clinical team calls patients for critical findings-about 12% of positives in 2025-providing care plans and referrals; this nursing oversight distinguishes LetsGetChecked from lifestyle DNA kits.
- 100% clinician review of critical results (2025)
- 12% of positives received clinician calls (2025)
- Supports regulatory compliance across US, UK, EU
- Medical-grade oversight vs. lifestyle DNA kits
Aggressive Customer Acquisition and Brand Marketing
LetsGetChecked spends aggressively on performance marketing, educational content, and influencer deals to stay top-of-mind in the crowded hospital-at-home space; 2025 spend rose to $78 million, up 22% YoY, with campaigns targeting 25-40-year-olds around "preventative maintenance."
Results: 2025 CAC fell 8% to $48, conversion from educational content rose 15%, and influencer-driven orders accounted for 12% of direct-to-consumer revenue ($45M).
- 2025 marketing spend $78M
- CAC $48 (-8% YoY)
- Influencer orders 12% ($45M)
- Edu-content conversion +15%
- Target demo 25-40, health-conscious
High-throughput CLIA/CAP labs processed ~3.2M tests in FY2025 (~150k/mo), 30% throughput growth YoY; in‑house kit assembly (60%) cut COGS to $9.80/kit and lifted gross margin to 48% after $32M capex; 100% critical result clinician review, 12% clinician calls; marketing spend $78M, CAC $48, influencer orders $45M (12%).
| Metric | 2025 |
|---|---|
| Tests processed | 3.2M |
| Monthly volume | 150k |
| COGS/kit | $9.80 |
| Gross margin | 48% |
| Capex | $32M |
| Marketing spend | $78M |
| CAC | $48 |
| Influencer revenue | $45M (12%) |
Full Document Unlocks After Purchase
Business Model Canvas
The document you're previewing is the actual LetsGetChecked Business Model Canvas, not a mockup-it's a direct snapshot of the file you'll receive after purchase.
When you complete your order, you'll instantly get this same professional, ready-to-use document in editable Word and Excel formats, structured and formatted exactly as shown.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Unlock LetsGetChecked's strategic playbook with our Business Model Canvas - a concise, actionable map of its value propositions, customer segments, partnerships, and revenue levers to help investors, founders, and strategists make smarter moves; download the full Word/Excel canvas to benchmark, adapt, and unlock growth opportunities.
Partnerships
By March 2026 LetsGetChecked integrates at API level with FedEx and UPS to enable overnight cold‑chain shipping for sensitive biomarkers, cutting median transit time to under 24 hours and preserving specimen integrity for 98% of overnight shipments.
LetsGetChecked secured shelf space in over 8,000 U.S. CVS and Walgreens locations by FY2025, enabling immediate kit pickup for the 'need-it-now' segment and driving a 14% uplift in monthly kit sales vs. digital-only channels.
This omnichannel footprint functions as a low-cost customer-acquisition channel-retail referrals cut online CAC by an estimated 22% in 2025 while adding physical brand touchpoints for a primarily cloud-based provider.
By 2025 LetsGetChecked became in-network with UnitedHealthcare and Aetna, letting millions use HSA funds or insurer coverage for at-home screenings; payer reimbursements drove revenue mix to an estimated 38% of US sales and supported a 2025 recurring revenue run-rate above $210M.
Laboratory Equipment Partnerships with Roche and Hologic
LetsGetChecked maintains CAP and CLIA certifications by deploying Roche and Hologic high-throughput molecular and immunoassay platforms, avoiding in-house hardware R&D and freeing 2025 capital to scale software and patient experience; Roche's Cobas 8800 and Hologic's Panther process thousands of tests/day, lowering per-test CAPEX.
- Roche Cobas 8800: ~1,440 tests/day throughput
- Hologic Panther: ~1,000+ tests/day, random access
- Outsourced hardware cuts capex, lets 2025 OPEX focus on software, UX, and logistics
Telehealth and Pharmacy Fulfillment Networks
LetsGetChecked ties diagnosis to treatment via partnerships with over 1,200 prescribing clinicians and pharmacy fulfillment partners, enabling instant virtual consults and e-prescriptions after a positive result-driving a 28% increase in treatment conversion in FY2025 and cutting time-to-therapy to 24 hours on average.
- 1,200+ prescribing clinicians (FY2025)
- 28% treatment conversion lift (FY2025)
- 24-hour median time-to-therapy
- Mail-order + local pharmacy coverage in 48 US states
Key partners-FedEx/UPS (API cold‑chain, 98% integrity, <24h), CVS/Walgreens (8,000+ stores; +14% kit sales), UnitedHealthcare/Aetna (in‑network; 38% of US sales; 2025 run‑rate >$210M), Roche/Hologic (outsourced platforms; high throughput), 1,200+ clinicians (28% treatment lift; 24h to therapy).
| Partner | Metric |
|---|---|
| FedEx/UPS | 98% integrity, <24h |
| CVS/Walgreens | 8,000+ stores, +14% sales |
| Payers | 38% US sales, $210M+ run‑rate |
| Roche/Hologic | ~1,440/1,000 tests/day |
| Clinicians | 1,200+, 28% conversion, 24h |
What is included in the product
A concise Business Model Canvas for LetsGetChecked outlining customer segments, value propositions, channels, revenue streams, key activities, resources, partners, cost structure, and risks-grounded in its telehealth diagnostics operations and investor-ready for presentations.
High-level view of LetsGetChecked's business model with editable cells to quickly map how at-home testing, telehealth, and recurring revenue streams relieve patient access and cost pain points.
Activities
High-throughput lab ops process ~150,000 patient samples/month (2025), using automated robotics and CLIA/CAP-compliant QC; throughput rose 30% YoY into 2026 while headcount grew just 8%, cutting per-sample processing cost ~18% versus 2024.
The engineering team turns raw lab results into clear patient guidance via proprietary algorithms; in FY2025 LetsGetChecked processed over 3.2 million tests and reported a 28% year-over-year increase in digital engagement, tying analytics to outcomes.
By 2025 LetsGetChecked brought ~60% of kit assembly in-house, cutting COGS per kit 18% to $9.80 and improving gross margin to 48%; the shift required $32m of capital spend and vertical sourcing of medical-grade swabs, reagents, and PPE across 3 continents.
Clinical Oversight and Nursing Support
Every LetsGetChecked result is reviewed by a licensed clinician; in 2025 the medical team reviewed 100% of positive/critical results, reducing adverse events and supporting regulatory compliance across US, UK, and EU operations.
The clinical team calls patients for critical findings-about 12% of positives in 2025-providing care plans and referrals; this nursing oversight distinguishes LetsGetChecked from lifestyle DNA kits.
- 100% clinician review of critical results (2025)
- 12% of positives received clinician calls (2025)
- Supports regulatory compliance across US, UK, EU
- Medical-grade oversight vs. lifestyle DNA kits
Aggressive Customer Acquisition and Brand Marketing
LetsGetChecked spends aggressively on performance marketing, educational content, and influencer deals to stay top-of-mind in the crowded hospital-at-home space; 2025 spend rose to $78 million, up 22% YoY, with campaigns targeting 25-40-year-olds around "preventative maintenance."
Results: 2025 CAC fell 8% to $48, conversion from educational content rose 15%, and influencer-driven orders accounted for 12% of direct-to-consumer revenue ($45M).
- 2025 marketing spend $78M
- CAC $48 (-8% YoY)
- Influencer orders 12% ($45M)
- Edu-content conversion +15%
- Target demo 25-40, health-conscious
High-throughput CLIA/CAP labs processed ~3.2M tests in FY2025 (~150k/mo), 30% throughput growth YoY; in‑house kit assembly (60%) cut COGS to $9.80/kit and lifted gross margin to 48% after $32M capex; 100% critical result clinician review, 12% clinician calls; marketing spend $78M, CAC $48, influencer orders $45M (12%).
| Metric | 2025 |
|---|---|
| Tests processed | 3.2M |
| Monthly volume | 150k |
| COGS/kit | $9.80 |
| Gross margin | 48% |
| Capex | $32M |
| Marketing spend | $78M |
| CAC | $48 |
| Influencer revenue | $45M (12%) |
Full Document Unlocks After Purchase
Business Model Canvas
The document you're previewing is the actual LetsGetChecked Business Model Canvas, not a mockup-it's a direct snapshot of the file you'll receive after purchase.
When you complete your order, you'll instantly get this same professional, ready-to-use document in editable Word and Excel formats, structured and formatted exactly as shown.











